Geert Walther Nygaard
Amministratore Delegato presso IBL International GmbH
Profilo
Geert Walther Nygaard is currently the Co-Managing Director at IBL International GmbH.
Previously, he was the Chief Executive Officer at Glycorex Transplantation AB from 2021 to 2022, and at Epigenomics AG from 2007 to 2010.
He also served as a Director at Abbott GmbH (Germany) in 2012.
Nygaard completed his undergraduate degree at the Technical University of Denmark.
Posizioni attive di Geert Walther Nygaard
Società | Posizione | Inizio |
---|---|---|
IBL International GmbH
IBL International GmbH Miscellaneous Commercial ServicesCommercial Services IBL International GmbH develops and produces products for the medical-diagnostics laboratories. The company provides research services in the fields of enzyme, radio and luminescence immunoassays. The firm provides products in the diagnostic fields of Endocrinology, Catecholamines, Neuroscience, Tumormarkers, Hypertension, Cytokines, Adhesion Molecules, Autoimmunity, Immunology and Infectious Diseases. IBL International was founded in 1983 and is headquartered in Hamburg, Germany. | Amministratore Delegato | - |
Precedenti posizioni note di Geert Walther Nygaard
Società | Posizione | Fine |
---|---|---|
GLYCOREX TRANSPLANTATION AB | Amministratore Delegato | 08/12/2022 |
EPIGENOMICS AG | Presidente | 30/09/2012 |
Abbott GmbH (Germany)
Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Abbott GmbH & Co. KG develops and manufactures health care products. It is engaged in the discovery, development, manufacture, and marketing of pharmaceutical, diagnostic, nutritional, and hospital products. It offers pharmaceutical and diagnostic products ranging from prevention and diagnosis to treatment and cure. The company is headquartered in Ludwigshafen, Germany. | Direttore/Membro del Consiglio | - |
Formazione di Geert Walther Nygaard
Technical University of Denmark | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
EPIGENOMICS AG | Health Technology |
GLYCOREX TRANSPLANTATION AB | Health Technology |
Aziende private | 2 |
---|---|
Abbott GmbH (Germany)
Abbott GmbH (Germany) Pharmaceuticals: MajorHealth Technology Abbott GmbH & Co. KG develops and manufactures health care products. It is engaged in the discovery, development, manufacture, and marketing of pharmaceutical, diagnostic, nutritional, and hospital products. It offers pharmaceutical and diagnostic products ranging from prevention and diagnosis to treatment and cure. The company is headquartered in Ludwigshafen, Germany. | Health Technology |
IBL International GmbH
IBL International GmbH Miscellaneous Commercial ServicesCommercial Services IBL International GmbH develops and produces products for the medical-diagnostics laboratories. The company provides research services in the fields of enzyme, radio and luminescence immunoassays. The firm provides products in the diagnostic fields of Endocrinology, Catecholamines, Neuroscience, Tumormarkers, Hypertension, Cytokines, Adhesion Molecules, Autoimmunity, Immunology and Infectious Diseases. IBL International was founded in 1983 and is headquartered in Hamburg, Germany. | Commercial Services |
- Borsa valori
- Insiders
- Geert Walther Nygaard